(R)-GSK-3685032 |
Katalog-Nr.GC64210 |
(R)-GSK-3685032 ist das R-Enantiomer von GSK-3685032. GSK-3685032 ist ein nicht zeitabhÄngiger, nicht kovalenter, erster reversibler DNMT1-selektiver Inhibitor seiner Klasse mit einem IC50-Wert von 0,036 μM. GSK-3685032 induziert einen starken Verlust der DNA-Methylierung, Transkriptionsaktivierung und Wachstumshemmung von Krebszellen.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2170140-50-6
Sample solution is provided at 25 µL, 10mM.
(R)-GSK-3685032 is the R-enantiomer of GSK-3685032. GSK-3685032 is a non-time-dependent, noncovalently, first-in-class reversible DNMT1-selective inhibitor, with an IC50 of 0.036 μM. GSK-3685032 induces robust loss of DNA methylation, transcriptional activation, and cancer cell growth inhibition[1][2].
[1]. Adams, Nicholas David, et al. Substituted pyridines as inhibitors of DNMT1 and their preparation. WO2017216727A1.
[2]. Pappalardi MB, et al. Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia. Nat Cancer. 2021;2(10):1002-1017.
Average Rating: 5
(Based on Reviews and 32 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *